Clinical trial

Semi-Quantification of Her2/Neu Protein Expression in Formalin Fixed, Paraffin-Embedded Normal and Neoplastic Tissue

NCT02654444

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2013-05-01

PhaseN/A

Study timeline

Study start (unknown)2013-05-01Date precision: month

Registry last updated2016-01-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

Sponsors & collaborators

Applied Spectral Imaging Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02654444 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.